PGT-A, PGT-M, and PGT-SR are advanced preimplantation genetic testing methods that help improve IVF/ICSI success by selecting embryos with the lowest risk of chromosomal or genetic abnormalities. While PGT-A focuses on chromosome number, PGT-M targets specific inherited diseases, and PGT-SR screens for structural chromosomal rearrangements. Choosing the right test based on medical history, age, and genetic risk allows couples to reduce miscarriage risk, improve implantation rates, and increase the chance of a healthy pregnancy, especially when undergoing PGT-A testing in Thailand at a specialised fertility centre.
Assisted reproductive technologies in 2025 are moving toward highly personalized fertility care, driven by more precise preimplantation genetic testing (PGT).
This article walks couples planning for parenthood through the differences between PGT-A, PGT-M, and PGT-SR. Highlighting how each test works, which conditions they are designed for, and how they can help maximize pregnancy success throughout the IVF/ICSI journey.
PGT-A (Preimplantation Genetic Testing for Aneuploidy) examines whether an embryo has the correct number of chromosomes, 46 in total, or whether there are missing chromosomes (monosomy) or extra chromosomes (trisomy). These abnormalities commonly cause Down syndrome (Trisomy 21), miscarriage, or failure of the embryo to implant or develop normally.
Benefits of PGT-A
Who Is a Good Candidate for PGT-A?
PGT-M (Preimplantation Genetic Testing for Monogenic/Single Gene Disorders) detects known mutations in single genes responsible for inherited diseases passed down from one or both parents. Examples include thalassemia, cystic fibrosis, and spinal muscular atrophy (SMA).
Benefits of PGT-M
Who Is a Good Candidate for PGT-M?
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) is designed for couples in which one partner carries a structural chromosomal rearrangement, such as a balanced translocation or inversion. Although carriers are usually healthy, they have an increased risk of producing embryos with unbalanced chromosomal structure, leading to recurrent miscarriage, failed pregnancies, or severe congenital disorders.
A balanced translocation occurs when two chromosomes exchange segments without losing or gaining genetic material. Problems arise during the formation of eggs or sperm, increasing the chance of embryos with missing or extra chromosomal segments.
Benefits of PGT-SR
Who Is a Good Candidate for PGT-SR?
PGT (Preimplantation Genetic Testing) is a technique used to analyze the genetic makeup of embryos before they are transferred into the uterus during IVF/ICSI. The goal is to analyze embryos to identify those that:
By examining chromosomal or genetic abnormalities before transfer, physicians can select embryos with the lowest risk of miscarriage, implantation failure, or congenital disorders. This is especially important for women over age 35, couples with a history of unexplained recurrent miscarriage, or couples with a family history of genetic disorder.
Benefits of PGT: Reducing Miscarriage and Genetic Risks
PGT helps fertility specialists identify embryos with minimal risk of chromosomal or genetic abnormalities. Key benefits include:
Factors Physicians Consider Before Selecting a PGT Method
Choosing the most appropriate type of PGT requires careful consideration of several medical factors and the couple’s history, such as:
Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR) empowers individuals facing infertility to select healthy embryos, reduce miscarriage risk, and enhance confidence in their IVF/ICSI success.
PGT itself is not painful because the biopsy step is performed on embryos in the laboratory following IVF or ICSI. It does not affect your body or harm the embryo. Testing usually takes 1–2 weeks, depending on the type of PGT (PGT-A, PGT-M, or PGT-SR) and the laboratory process used.
Yes. Extensive medical data show that PGT-A, PGT-M, and PGT-SR significantly improve pregnancy success rates by helping identify embryos that are chromosomally normal and healthy (euploid). This reduces miscarriage, failed implantation, and risks of genetic disorders—especially for women over 35 or couples with a history of recurrent pregnancy loss.
While PGT is highly effective at reducing the risk of transferring abnormal embryos, it has limitations. It cannot guarantee pregnancy because factors such as uterine health and overall well-being also play a role. Some very small chromosomal abnormalities (microdeletions or microduplications) may not be detectable. Additionally, PGT must be performed as part of an IVF/ICSI cycle.
For these reasons, it is recommended to consult a reproductive specialist to determine suitability and create a personalized treatment plan.